Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
Funds developing an assay and screening to identify a therapeutic agent, ahead of characterisation and efficacy testing on it.
Before any therapeutic agent can be tested for efficacy, someone has to build the assay that can find it and screen enough candidates to identify one worth testing.
This half of the IGNITE pair funds that earlier stage: developing in vitro, ex vivo or in vivo assays and running screening efforts to identify and characterise potential therapeutic agents — small molecules or biologics — for disorde…
Development of in vitro, ex vivo or in vivo assays and screening efforts to identify and characterise potential small-molecule or biologic therapeutic agents, for disorders within participating institutes' missions or for non-opioid analgesics with little or no addiction liability under the NIH HEAL initiative, with assays built on New Approach Methodologies where appropriate.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up